Home LiteratureArticle Details
PMID: 17144911 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

The strength of the HIV-1 3' splice sites affects Rev function.

Retrovirology ·Vol. 3 ·2006-12-04 ·Pages 89

Kammler S, Otte M, Hauber I, Kjems J, Hauber J, Schaal H

Abstract

The HIV-1 Rev protein is a key component in the early to late switch in HIV-1 splicing from early intronless (e.g. tat, rev) to late intron-containing Rev-dependent (e.g. gag, vif, env) transcripts. Previous results suggested that cis-acting sequences and inefficient 5' and 3' splice sites are a prerequisite for Rev function. However, we and other groups have shown that two of the HIV-1 5' splice sites, D1 and D4, are efficiently used in vitro and in vivo. Here, we focus on the efficiency of the HIV-1 3' splice sites taking into consideration to what extent their intrinsic efficiencies are modulated by their downstream cis-acting exonic sequences. Furthermore, we delineate their role in RNA stabilization and Rev function. In the presence of an efficient upstream 5' splice site the integrity of the 3' splice site is not essential for Rev function whereas an efficient 3' splice site impairs Rev function. The detrimental effect of a strong 3' splice site on the amount of Rev-dependent intron-containing HIV-1 glycoprotein coding (env) mRNA is not compensatable by weakening the strength of the upstream 5' splice site. Swapping the HIV-1 3' splice sites in an RRE-containing minigene, we found a 3' splice site usage which was variably dependent on the presence of the usual downstream exonic sequence. The most evident activation of 3' splice site usage by its usual downstream exonic sequence was observed for 3' splice site A1 which was turned from an intrinsic very weak 3' splice site into the most active 3' splice site, even abolishing Rev activity. Performing pull-down experiments with nuclear extracts of HeLa cells we identified a novel ASF/SF2-dependent exonic splicing enhancer (ESE) within HIV-1 exon 2 consisting of a heptameric sequence motif occurring twice (M1 and M2) within this short non-coding leader exon. Single point mutation of M1 within an infectious molecular clone is detrimental for HIV-1 exon 2 recognition without affecting Rev-dependent vif expression. Under the conditions of our assay, the rate limiting step of retroviral splicing, competing with Rev function, seems to be exclusively determined by the functional strength of the 3' splice site. The bipartite ASF/SF2-dependent ESE within HIV-1 exon 2 supports cross-talk between splice site pairs across exon 2 (exon definition) which is incompatible with processing of the intron-containing vif mRNA. We propose that Rev mediates a switch from exon to intron definition necessary for the expression of all intron-containing mRNAs.

MeSH Terms
3' Untranslated Regions/genetics Enhancer Elements, Genetic Exons/genetics Gene Products, rev/metabolism Genes, rev HIV-1/genetics,metabolism HeLa Cells Humans Introns/genetics RNA Splicing RNA, Messenger/genetics,metabolism RNA, Viral/genetics,metabolism rev Gene Products, Human Immunodeficiency Virus
Chemicals
3' Untranslated Regions Gene Products, rev RNA, Messenger RNA, Viral rev Gene Products, Human Immunodeficiency Virus
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kammler Susanne
Institut für Virologie, Heinrich-Heine-Universität Düsseldorf, Universitätsstr, 1, Geb, 22,21, D-40225 Düsseldorf, Germany. [email protected]
Otte Marianne
Hauber Ilona
Kjems Jørgen
Hauber Joachim
Schaal Heiner
References (65)
65 references, click to expand
  1. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.
    Mol Cell Biol. 1998 Sep;18(9):5404-13 PMID: 9710624
  2. Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns.
    Mol Cell Biol. 1993 Aug;13(8):4939-52 PMID: 8336728
  3. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.
    J Virol. 1993 Nov;67(11):6365-78 PMID: 8411338
  4. Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs.
    J Biol Chem. 1998 Dec 18;273(51):34551-7 PMID: 9852125
  5. Substrate specificities of SR proteins in constitutive splicing are determined by their RNA recognition motifs and composite pre-mRNA exonic elements.
    Mol Cell Biol. 1999 Mar;19(3):1853-63 PMID: 10022872
  6. hnRNP A/B proteins are required for inhibition of HIV-1 pre-mRNA splicing.
    EMBO J. 1999 Jul 15;18(14):4060-7 PMID: 10406810
  7. Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end.
    Nucleic Acids Res. 2005;33(3):825-37 PMID: 15701754
  8. Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors.
    Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8764-9 PMID: 15939885
  9. Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production.
    Retrovirology. 2005;2:33 PMID: 15907217
  10. An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication.
    J Virol. 2005 Aug;79(16):10478-86 PMID: 16051840
  11. The spliceosome: a novel multi-faceted target for therapy.
    Trends Biochem Sci. 2005 Aug;30(8):469-78 PMID: 16009556
  12. Extended base pair complementarity between U1 snRNA and the 5' splice site does not inhibit splicing in higher eukaryotes, but rather increases 5' splice site recognition.
    Nucleic Acids Res. 2005;33(16):5112-9 PMID: 16155183
  13. Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing.
    Curr HIV Res. 2006 Jan;4(1):43-55 PMID: 16454710
  14. A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.
    Retrovirology. 2006;3:10 PMID: 16457729
  15. The retrovirus RNA trafficking granule: from birth to maturity.
    Retrovirology. 2006;3:18 PMID: 16545126
  16. A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability.
    J Biol Chem. 2006 Jul 7;281(27):18644-51 PMID: 16675444
  17. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    J Virol. 1999 Dec;73(12):9764-72 PMID: 10559286
  18. Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing.
    Nucleic Acids Res. 2001 Jan 15;29(2):464-78 PMID: 11139617
  19. The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.
    RNA. 2001 Mar;7(3):421-34 PMID: 11333022
  20. RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element.
    J Virol. 2001 Sep;75(18):8487-97 PMID: 11507194
  21. SF2/ASF binds to a splicing enhancer in the third HIV-1 tat exon and stimulates U2AF binding independently of the RS domain.
    J Mol Biol. 2001 Sep 28;312(4):649-62 PMID: 11575921
  22. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
    EMBO J. 2001 Oct 15;20(20):5748-58 PMID: 11598017
  23. A second exon splicing silencer within human immunodeficiency virus type 1 tat exon 2 represses splicing of Tat mRNA and binds protein hnRNP H.
    J Biol Chem. 2001 Nov 2;276(44):40464-75 PMID: 11526107
  24. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Mol Cell. 2001 Dec;8(6):1351-61 PMID: 11779509
  25. SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D.
    EMBO J. 2002 Feb 15;21(4):845-55 PMID: 11847131
  26. A Janus splicing regulatory element modulates HIV-1 tat and rev mRNA production by coordination of hnRNP A1 cooperative binding.
    J Mol Biol. 2002 Nov 1;323(4):629-52 PMID: 12419255
  27. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
    RNA. 2002 Nov;8(11):1401-15 PMID: 12458794
  28. HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim.
    EMBO J. 2002 Dec 16;21(24):6801-10 PMID: 12486001
  29. Mechanism of HIV-1 viral protein R-induced apoptosis.
    Biochem Biophys Res Commun. 2003 May 9;304(3):583-92 PMID: 12729593
  30. ESEfinder: A web resource to identify exonic splicing enhancers.
    Nucleic Acids Res. 2003 Jul 1;31(13):3568-71 PMID: 12824367
  31. Control of HIV-1 env RNA splicing and transport: investigating the role of hnRNP A1 in exon splicing silencer (ESS3a) function.
    Virology. 2003 Sep 15;314(1):229-42 PMID: 14517076
  32. A novel approach to describe a U1 snRNA binding site.
    Nucleic Acids Res. 2003 Dec 1;31(23):6963-75 PMID: 14627829
  33. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.
    J Biol Chem. 2004 Mar 12;279(11):10077-84 PMID: 14703516
  34. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    J Virol. 2004 Jun;78(12):6517-26 PMID: 15163745
  35. Solution structure of the pseudo-5' splice site of a retroviral splicing suppressor.
    RNA. 2004 Sep;10(9):1388-98 PMID: 15317975
  36. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.
    Cell. 1986 Nov 7;47(3):333-48 PMID: 3094962
  37. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  38. The HIV 'A' (sor) gene product is essential for virus infectivity.
    Nature. 1987 Aug 20-26;328(6132):728-30 PMID: 2441266
  39. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1988 Apr;85(7):2071-5 PMID: 2832844
  40. Regulation by HIV Rev depends upon recognition of splice sites.
    Cell. 1989 Dec 1;59(5):789-95 PMID: 2686839
  41. A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins.
    J Virol. 1990 Jun;64(6):2505-18 PMID: 2186172
  42. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.
    J Virol. 1990 Jun;64(6):2519-29 PMID: 2335812
  43. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.
    J Virol. 1990 Jul;64(7):3391-8 PMID: 2191150
  44. U1 small nuclear RNA plays a direct role in the formation of a rev-regulated human immunodeficiency virus env mRNA that remains unspliced.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7598-602 PMID: 2217190
  45. Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel tat-env fusion protein.
    Virology. 1991 Nov;185(1):258-70 PMID: 1926777
  46. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.
    J Virol. 1992 Dec;66(12):7176-82 PMID: 1433510
  47. Use of DNA end joining activity of a Xenopus laevis egg extract for construction of deletions and expression vectors for HIV-1 Tat and Rev proteins.
    Gene. 1993 Feb 28;124(2):275-80 PMID: 8444351
  48. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA.
    J Virol. 1994 May;68(5):2986-93 PMID: 8151769
  49. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
    Mol Cell Biol. 1994 Jun;14(6):3960-70 PMID: 8196635
  50. A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation.
    EMBO J. 1994 Sep 1;13(17):4096-104 PMID: 8076605
  51. Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA.
    EMBO J. 1994 Sep 1;13(17):4105-12 PMID: 8076606
  52. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion.
    J Virol. 1995 Jun;69(6):3308-14 PMID: 7745678
  53. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
    Mol Cell Biol. 1995 Aug;15(8):4597-605 PMID: 7623851
  54. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Mol Cell Biol. 1995 Aug;15(8):4606-15 PMID: 7623852
  55. Inefficient spliceosome assembly and abnormal branch site selection in splicing of an HIV-1 transcript in vitro.
    J Biol Chem. 1995 Oct 13;270(41):24060-6 PMID: 7592605
  56. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.
    Virology. 1995 Nov 10;213(2):373-85 PMID: 7491762
  57. Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs.
    J Mol Biol. 1996 Mar 29;257(2):246-64 PMID: 8609621
  58. Three recognition events at the branch-site adenine.
    EMBO J. 1996 Mar 15;15(6):1392-402 PMID: 8635472
  59. In vitro interaction between human immunodeficiency virus type 1 Rev protein and splicing factor ASF/SF2-associated protein, p32.
    J Biol Chem. 1996 Apr 26;271(17):10066-72 PMID: 8626563
  60. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.
    Nucleic Acids Res. 1997 Feb 15;25(4):861-7 PMID: 9016638
  61. Exon 1 leader sequences downstream of U5 are important for efficient human immunodeficiency virus type 1 gene expression.
    J Virol. 1997 Apr;71(4):2757-64 PMID: 9060629
  62. The D1-A2 and D2-A2 pairs of splice sites from human immunodeficiency virus type 1 are highly efficient in vitro, in spite of an unusual branch site.
    Biochem Biophys Res Commun. 1997 Aug 8;237(1):182-7 PMID: 9266854
  63. CRM1 is an export receptor for leucine-rich nuclear export signals.
    Cell. 1997 Sep 19;90(6):1051-60 PMID: 9323133
  64. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
    J Virol. 1997 Nov;71(11):8542-51 PMID: 9343212
  65. CRM1 is responsible for intracellular transport mediated by the nuclear export signal.
    Nature. 1997 Nov 20;390(6657):308-11 PMID: 9384386
Article Info
Journal
Retrovirology
Abbr.
Retrovirology
ISSN
1742-4690
Published
2006-12-04
Epub
2006-00-04
Pages
89
Language
English
Region
England
NLM ID
101216893
PMCID
PMC1697824
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]